• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病中2型糖尿病发生风险因素的多变量分析

Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease.

作者信息

Arase Yasuji, Suzuki Fumitaka, Ikeda Kenji, Kumada Hiromitsu, Tsuji Hiroshi, Kobayashi Tetsuro

机构信息

Department of Hepatology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan.

出版信息

J Gastroenterol. 2009;44(10):1064-70. doi: 10.1007/s00535-009-0091-1. Epub 2009 Jun 17.

DOI:10.1007/s00535-009-0091-1
PMID:19533014
Abstract

PURPOSE

Diabetes is present in patients with nonalcoholic fatty liver disease (NAFLD). The aim of this retrospective cohort study was to assess the cumulative development of type 2 diabetes and predictive factors for its development in Japanese patients with NAFLD.

METHODS

A total of 6003 NAFLD patients diagnosed by ultrasonography were enrolled. The mean follow-up period was 4.9 years. An overnight (12 h) fasting blood sample or a casual blood sample was taken for routine analyses during follow up. The primary outcome was the development of type 2 diabetes. Evaluation was performed by using the Kaplan-Meier method and Cox proportional hazards analysis.

RESULTS

Of the 6003 NAFLD patients, 411 patients developed type 2 diabetes. The cumulative development rate of type 2 diabetes was 6.8% at the 5th year and 17.7% at the 10th year. Multivariate Cox proportional hazards analysis showed that type 2 diabetes development in patients with NAFLD occurred when patients had prediabetes status (hazard ratio 6.39; 95% confidence interval 5.00-8.18; P < 0.001), mean serum gamma-glutamyltransferase (GGT) level of more than 109 IU/l (hazard ratio 1.60; 95% confidence interval 1.22-2. 02; P < 0.001), mean serum triglyceride (TG) level of more than 150 mg/l (hazard ratio 1.28; 95% confidence interval 1.05-1.55; P = 0.020), and physical activity of less than 60 min per week (hazard ratio 1.60; 95% confidence interval 1.25-2.00; P < 0.001).

CONCLUSIONS

The improvement of prediabetes status and physical activity, and the normalization of mean GGT and TG levels during follow up are important to prevent the development of T2DM in patients with NAFLD.

摘要

目的

非酒精性脂肪性肝病(NAFLD)患者中存在糖尿病。这项回顾性队列研究的目的是评估日本NAFLD患者2型糖尿病的累积发病率及其发病的预测因素。

方法

共纳入6003例经超声诊断的NAFLD患者。平均随访期为4.9年。随访期间采集过夜(12小时)空腹血样或随机血样进行常规分析。主要结局是2型糖尿病的发生。采用Kaplan-Meier法和Cox比例风险分析进行评估。

结果

6003例NAFLD患者中,411例发生2型糖尿病。2型糖尿病的累积发病率在第5年为6.8%,在第10年为17.7%。多因素Cox比例风险分析显示,NAFLD患者出现2型糖尿病的情况为:有糖尿病前期状态(风险比6.39;95%置信区间5.00-8.18;P<0.001)、平均血清γ-谷氨酰转移酶(GGT)水平超过109 IU/l(风险比1.60;95%置信区间1.22-2.02;P<0.001)、平均血清甘油三酯(TG)水平超过150 mg/l(风险比1.28;95%置信区间1.05-1.55;P=0.020)以及每周体力活动少于60分钟(风险比1.60;95%置信区间1.25-2.00;P<0.001)。

结论

改善糖尿病前期状态和体力活动,以及随访期间使平均GGT和TG水平正常化,对于预防NAFLD患者发生2型糖尿病很重要。

相似文献

1
Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中2型糖尿病发生风险因素的多变量分析
J Gastroenterol. 2009;44(10):1064-70. doi: 10.1007/s00535-009-0091-1. Epub 2009 Jun 17.
2
The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease.日本非酒精性脂肪性肝病患者慢性肾脏病的发展
Intern Med. 2011;50(10):1081-7. doi: 10.2169/internalmedicine.50.5043. Epub 2011 May 1.
3
Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study.中国西安的一项为期五年的队列研究:非酒精性脂肪性肝病可预测2型糖尿病,但不能预测糖尿病前期。
Liver Int. 2015 Nov;35(11):2401-7. doi: 10.1111/liv.12851. Epub 2015 May 5.
4
Gamma-glutamyltransferase levels, prediabetes and type 2 diabetes: a Mendelian randomization study.γ-谷氨酰转移酶水平、糖尿病前期和 2 型糖尿病:一项孟德尔随机研究。
Int J Epidemiol. 2017 Oct 1;46(5):1400-1409. doi: 10.1093/ije/dyx006.
5
Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C.持续病毒学应答可降低慢性丙型肝炎患者2型糖尿病的发病几率。
Hepatology. 2009 Mar;49(3):739-44. doi: 10.1002/hep.22703.
6
Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: the Bogalusa Heart Study.肝功能酶升高与年轻成年人发生糖尿病前期和 2 型糖尿病有关:博加卢萨心脏研究。
Diabetes Care. 2011 Dec;34(12):2603-7. doi: 10.2337/dc11-0919. Epub 2011 Sep 27.
7
Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.肥胖与非酒精性脂肪性肝病对2型糖尿病发病率影响的比较。
World J Gastroenterol. 2015 Aug 28;21(32):9607-13. doi: 10.3748/wjg.v21.i32.9607.
8
Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study.非酒精性脂肪性肝病的临床可用性作为韩国男性 2 型糖尿病的早期预测指标:一项 5 年前瞻性队列研究。
Hepatology. 2013 Apr;57(4):1378-83. doi: 10.1002/hep.26183.
9
Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus.改善非酒精性脂肪性肝病可降低 2 型糖尿病的发病风险。
Gut Liver. 2019 Apr 17;13(4):440-449. doi: 10.5009/gnl18382.
10
Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.血清γ-谷氨酰转移酶:糖尿病、高血压、代谢综合征和冠心病风险的独立预测因子。
Obesity (Silver Spring). 2012 Apr;20(4):842-8. doi: 10.1038/oby.2011.136. Epub 2011 Jun 2.

引用本文的文献

1
Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summary.基层医疗中代谢功能障碍相关脂肪性肝病的评估:共识声明摘要
Med J Aust. 2025 Sep 1;223(5):268-276. doi: 10.5694/mja2.70008. Epub 2025 Jul 28.
2
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.非酒精性脂肪性肝病或代谢相关脂肪性肝病患者 2 型糖尿病的全球流行病学:系统评价和荟萃分析。
BMC Med. 2024 Mar 6;22(1):101. doi: 10.1186/s12916-024-03315-0.
3
Efficacy of 3 months of additional pioglitazone treatment in type 2 diabetes patients with alcoholic fatty liver disease.

本文引用的文献

1
Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis.丙氨酸转氨酶、γ-谷氨酰转移酶与新发糖尿病:英国女性心脏与健康研究及荟萃分析
Diabetes Care. 2009 Apr;32(4):741-50. doi: 10.2337/dc08-1870. Epub 2009 Jan 8.
2
Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C.持续病毒学应答可降低慢性丙型肝炎患者2型糖尿病的发病几率。
Hepatology. 2009 Mar;49(3):739-44. doi: 10.1002/hep.22703.
3
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management.
3个月额外吡格列酮治疗对2型糖尿病合并酒精性脂肪性肝病患者的疗效。
Diabetol Int. 2023 Feb 18;14(3):243-251. doi: 10.1007/s13340-023-00619-z. eCollection 2023 Jul.
4
Association Between Liver Fat and Bone Density is Confounded by General and Visceral Adiposity in a Community-Based Cohort.在一个基于社区的队列研究中,肝脏脂肪与骨密度之间的关联受到总体和内脏脂肪过多的混淆。
Obesity (Silver Spring). 2021 Mar;29(3):595-600. doi: 10.1002/oby.23100. Epub 2021 Feb 2.
5
Epidemiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: A focused literature review.日本非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学:文献综述
JGH Open. 2020 May 5;4(5):808-817. doi: 10.1002/jgh3.12349. eCollection 2020 Oct.
6
Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study.脂肪肝指数是预测前驱糖尿病患者发生糖尿病的指标:PREDAPS 研究。
PLoS One. 2018 Jun 1;13(6):e0198327. doi: 10.1371/journal.pone.0198327. eCollection 2018.
7
A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study.一种简单的临床模型可预测基于社区人群的肝脂肪变性事件:弗雷明汉心脏研究。
Liver Int. 2018 Aug;38(8):1495-1503. doi: 10.1111/liv.13709. Epub 2018 Mar 12.
8
High-Intensity Aerobic Exercise Improves Both Hepatic Fat Content and Stiffness in Sedentary Obese Men with Nonalcoholic Fatty Liver Disease.高强度有氧运动可改善非酒精性脂肪性肝病的久坐肥胖男性的肝内脂肪含量和硬度。
Sci Rep. 2017 Feb 22;7:43029. doi: 10.1038/srep43029.
9
Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.肥胖与非酒精性脂肪性肝病对2型糖尿病发病率影响的比较。
World J Gastroenterol. 2015 Aug 28;21(32):9607-13. doi: 10.3748/wjg.v21.i32.9607.
10
Efficacy and safety of sitagliptin for the treatment of diabetes mellitus complicated by chronic liver injury.西他列汀治疗合并慢性肝损伤的糖尿病的疗效与安全性。
Springerplus. 2015 Jul 15;4:346. doi: 10.1186/s40064-015-1135-z. eCollection 2015.
非酒精性脂肪性肝病和非酒精性脂肪性肝炎:评估与管理中的若干实际问题
Hepatology. 2009 Jan;49(1):306-17. doi: 10.1002/hep.22603.
4
Epidemiology of non-alcoholic fatty liver disease in China.中国非酒精性脂肪性肝病的流行病学
J Hepatol. 2009 Jan;50(1):204-10. doi: 10.1016/j.jhep.2008.10.010. Epub 2008 Nov 6.
5
Liver diseases and metabolic syndrome.肝脏疾病与代谢综合征。
J Gastroenterol. 2008;43(7):509-18. doi: 10.1007/s00535-008-2193-6. Epub 2008 Jul 23.
6
Visceral fat: a key mediator of steatohepatitis in metabolic liver disease.内脏脂肪:代谢性肝病中脂肪性肝炎的关键介质。
Hepatology. 2008 Aug;48(2):449-57. doi: 10.1002/hep.22350.
7
Diagnosis and therapy of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的诊断与治疗
Gastroenterology. 2008 May;134(6):1682-98. doi: 10.1053/j.gastro.2008.02.077.
8
Elevated serum aminotransferase levels in children at risk for obstructive sleep apnea.阻塞性睡眠呼吸暂停高危儿童血清转氨酶水平升高。
Chest. 2008 Jan;133(1):92-9. doi: 10.1378/chest.07-0773.
9
Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage.目前体内评估胰岛素敏感性和抵抗性的方法:优点、局限性及合理应用。
Am J Physiol Endocrinol Metab. 2008 Jan;294(1):E15-26. doi: 10.1152/ajpendo.00645.2007. Epub 2007 Oct 23.
10
Metabolic correlates of nonalcoholic fatty liver in women and men.女性和男性非酒精性脂肪肝的代谢相关性
Hepatology. 2007 Sep;46(3):716-22. doi: 10.1002/hep.21727.